Cargando…
Could the Induction of Trained Immunity by β-Glucan Serve as a Defense Against COVID-19?
As the SARS-CoV-2 virus wreaks havoc on the populations, health care infrastructures and economies of nations around the world, finding ways to protect health care workers and bolster immune responses in the general population while we await an effective vaccine will be the difference between life a...
Autores principales: | Geller, Anne, Yan, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372085/ https://www.ncbi.nlm.nih.gov/pubmed/32760409 http://dx.doi.org/10.3389/fimmu.2020.01782 |
Ejemplares similares
-
β-Glucan-Induced Trained Immunity in Dogs
por: Paris, Simon, et al.
Publicado: (2020) -
β-Glucan as Trained Immunity-Based Adjuvants for Rabies Vaccines in Dogs
por: Paris, Simon, et al.
Publicado: (2020) -
Commentary: Beyond “TRIM” Benefits of β-Glucan by Blood Glucose and Lipid Balancing Potentials in Its Defense Against COVID-19
por: Ikewaki, Nobunao, et al.
Publicado: (2021) -
Continuous Exposure to Non-Soluble β-Glucans Induces Trained Immunity in M-CSF-Differentiated Macrophages
por: Moerings, Bart G. J., et al.
Publicado: (2021) -
Yeast-Derived β-Glucan in Cancer: Novel Uses of a Traditional Therapeutic
por: Geller, Anne, et al.
Publicado: (2019)